Key result
Recombinant VHH antibody S1-C7 specifically binds and neutralizes Sabin type 1 poliovirus D-antigen.
Why the study?
The D-antigen of poliovirus is critical for inducing protective immunity, making the development of quantitative immunoassays to monitor D-antigen content during inactivated polio vaccine production an important task.
The generated VHH antibodies, particularly clone S1-C7, provide a promising analytical tool for strain-specific recognition and quantification of poliovirus D-antigen during vaccine production.
May aid strain-specific polio vaccine monitoring; leaves open clinical translation pending further validation.
Vaccination remains the primary strategy for poliomyelitis prevention. The D-antigen of poliovirus is a critical component of inactivated polio vaccines, as it induces the production of neutralizing antibodies and provides protective immunity. Therefore, the development of quantitative immunoassays for monitoring D-antigen content during vaccine production is an important task. In this study, we generated recombinant camelid single-domain antibodies (VHHs) specific for the D-antigen of Sabin poliovirus type 1 and evaluated their antigen specificity. The obtained VHH antibodies demonstrated strong binding to the native D-antigen of Sabin type 1 poliovirus. Furthermore, the use of clone S1-C7 as a capture antibody in combination with Sabin type 1-specific polyclonal antibodies for detection revealed differential recognition of the vaccine-derived Sabin type 1 and homologous wild-type Mahoney strains. Notably, such discrimination was not observed when polyclonal antibodies were used alone, indicating that incorporation of VHH S1-C7 into the assay enhances strain-specific antigen recognition. In a neutralization assay, clone S1-C7 exhibited in vitro neutralizing activity against Sabin type 1 poliovirus. One clone, S1-D9, demonstrated cross-reactivity with all three poliovirus serotypes, suggesting recognition of a conserved epitope in the capsid and potential utility as a universal detection antibody. The generated VHH antibodies represent promising analytical tools for poliovirus antigen characterization. Together with S1-C7, they enable the discrimination of both D- and C-antigen forms as well as vaccine-derived and wild-type strains.
No takes yet. Share an insight, caveat, or question.
Ermakova et al. (2026) studied Poliovirus. VHH antibodies against Sabin type 1 poliovirus D-antigen vs. Polyclonal antibodies was evaluated on Antigen specificity and neutralizing activity. Recombinant VHH antibodies, notably clone S1-C7, exhibited strain-specific recognition and in vitro neutralizing activity against the Sabin type 1 poliovirus D-antigen.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: